RVL Pharmaceuticals plc – NASDAQ:RVLP

Financial Health
0
1
2
3
4
5
6
7
8
9

RVL Pharmaceuticals stock price monthly change

-76.07%
month

RVL Pharmaceuticals stock price quarterly change

-96.46%
quarter

RVL Pharmaceuticals stock price yearly change

-98.37%
year

RVL Pharmaceuticals key metrics

Market Cap
3.14M
Enterprise value
116.21M
P/E
-1.92
EV/Sales
1.45
EV/EBITDA
-1.79
Price/Sales
1.29
Price/Book
2.02
PEG ratio
-0.04
EPS
-0.70
Revenue
36.91M
EBITDA
-36.33M
Income
-68.26M
Revenue Q/Q
-2.24%
Revenue Y/Y
5.63%
Profit margin
-88.7%
Oper. margin
-34.92%
Gross margin
82.63%
EBIT margin
-34.92%
EBITDA margin
-98.42%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

RVL Pharmaceuticals stock price history

RVL Pharmaceuticals stock forecast

RVL Pharmaceuticals financial statements

RVL Pharmaceuticals plc (NASDAQ:RVLP): Profit margin
Sep 2022 10.02M -14.44M -144.14%
Dec 2022 9.80M -18.31M -186.8%
Mar 2023 8.83M -11.61M -131.48%
Jun 2023 8.25M -23.88M -289.28%
RVL Pharmaceuticals plc (NASDAQ:RVLP): Debt to assets
Sep 2022 155355000 86.80M 55.88%
Dec 2022 128510000 77.41M 60.24%
Mar 2023 111108000 71.10M 64%
Jun 2023 85404000 69.07M 80.88%
RVL Pharmaceuticals plc (NASDAQ:RVLP): Cash Flow
Sep 2022 -10.09M 231K 42.20M
Dec 2022 -16.43M -172K 1.39M
Mar 2023 -5.81M -1.22M -4.86M
Jun 2023 -12.06M -959K -460K

RVL Pharmaceuticals alternative data

RVL Pharmaceuticals plc (NASDAQ:RVLP): Employee count
Aug 2023 125
Sep 2023 125
Oct 2023 125
Nov 2023 125
Dec 2023 125
Jan 2024 125
Feb 2024 125
Mar 2024 125
Apr 2024 125
May 2024 125
Jun 2024 125
Jul 2024 125

RVL Pharmaceuticals other data

6.79% -20.60%
of RVLP is owned by hedge funds
6.09M -19.30M
shares is hold by hedge funds

RVL Pharmaceuticals plc (NASDAQ:RVLP): Insider trades (number of shares)
Period Buy Sel
Oct 2023 0 25724632
Transaction Date Insider Security Shares Price per share Total value Source
Sale
ALTCHEM LTD 10 percent owner
Ordinary Shares 4,758,899 $0.03 $147,526
Sale
HARSAUL FOUNDATION 10 percent owner
Ordinary Shares 4,758,899 $0.03 $147,526
Sale
ALTCHEM LTD 10 percent owner
Ordinary Shares 9,363,760 $0.05 $430,733
Sale
HARSAUL FOUNDATION 10 percent owner
Ordinary Shares 3,421,537 $0.07 $222,400
Sale
ALTCHEM LTD 10 percent owner
Ordinary Shares 3,421,537 $0.07 $222,400
Purchase
AVISTA HEALTHCARE PARTNERS, L.P. 10 percent owner
Ordinary Shares 8,000,000 $1.55 $12,400,000
Purchase
VENKATARAMAN SRIRAM director, 10 percent owner
Ordinary Shares 8,000,000 $1.55 $12,400,000
Purchase
BURGSTAHLER DAVID F director, 10 percent owner
Ordinary Shares 8,000,000 $1.55 $12,400,000
Purchase
MARKISON BRIAN A director, officer.. Ordinary Shares 850,000 $1.55 $1,317,500
Purchase
SCHAUB JAMES officer: EVP and .. Ordinary Shares 150,000 $1.55 $232,500
  • When is RVL Pharmaceuticals's next earnings date?

    Unfortunately, RVL Pharmaceuticals's (RVLP) next earnings date is currently unknown.

  • Does RVL Pharmaceuticals pay dividends?

    No, RVL Pharmaceuticals does not pay dividends.

  • How much money does RVL Pharmaceuticals make?

    RVL Pharmaceuticals has a market capitalization of 3.14M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 184.1% to 49.72M US dollars.

  • What is RVL Pharmaceuticals's stock symbol?

    RVL Pharmaceuticals plc is traded on the NASDAQ under the ticker symbol "RVLP".

  • What is RVL Pharmaceuticals's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of RVL Pharmaceuticals?

    Shares of RVL Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does RVL Pharmaceuticals have?

    As Jul 2024, RVL Pharmaceuticals employs 125 workers.

  • When RVL Pharmaceuticals went public?

    RVL Pharmaceuticals plc is publicly traded company for more then 6 years since IPO on 19 Oct 2018.

  • What is RVL Pharmaceuticals's official website?

    The official website for RVL Pharmaceuticals is rvlpharma.com.

  • Where are RVL Pharmaceuticals's headquarters?

    RVL Pharmaceuticals is headquartered at 400 Crossing Boulevard, Bridgewater, NJ.

  • How can i contact RVL Pharmaceuticals?

    RVL Pharmaceuticals's mailing address is 400 Crossing Boulevard, Bridgewater, NJ and company can be reached via phone at +90 88091300.

RVL Pharmaceuticals company profile:

RVL Pharmaceuticals plc

rvlpharma.com
Exchange:

NASDAQ

Full time employees:

125

Industry:

Biotechnology

Sector:

Healthcare

RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

400 Crossing Boulevard
Bridgewater, NJ 08807

CIK: 0001739426
ISIN: IE00BF2HDL56
CUSIP: G6S41R101